Back to Markets
GIGilead Sciences

Gilead Sciences

GILDNASDAQ NMS - GLOBAL MARKET
HealthcareBiotechnology

$134.43

-1.790000 (-1.31%)

As of 05/29/26 EDT · USD

Compare
Low: $104.46Current: $134.43High: $157.29

Key Statistics

Open

$135.13

Day High

$137.20

Day Low

$133.55

Prev. Close

$136.22

VolumeShares traded today.

11.32M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$166.90B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

18.29

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$157.29

52W LowLowest price over the past 52 weeks.

$104.46

50D MAAverage closing price over the last 50 trading days.

$135.10

200D MAAverage closing price over the last 200 trading days.

$128.66

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+3.0%

1M

+4.3%

6M

+5.8%

YTD

+10.6%

1Y

+22.1%

About

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.

www.gilead.com

Company Facts

SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade GILD

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.